|
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2013
|
Mar. 31, 2012
|
|
| Segment Reporting Information [Line Items] | ||||
| External sales | $ 80,992 | $ 83,621 | $ 231,100 | $ 235,879 |
| Earnings before income taxes | 44,466 | 43,205 | 119,898 | 121,578 |
|
Biotechnology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 75,285 | 78,180 | 214,416 | 220,291 |
| Earnings before income taxes | 43,246 | 45,442 | 117,123 | 123,304 |
|
Hematology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 5,707 | 5,441 | 16,684 | 15,588 |
| Earnings before income taxes | 2,247 | 2,037 | 6,498 | 5,636 |
|
Reportable Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | 45,493 | 47,479 | 123,621 | 128,940 |
|
Unallocated Amount to Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | $ (1,027) | $ (4,274) | $ (3,723) | $ (7,362) |